Breast Cancer Analysis in DCE-MRI

Breast cancer is the most common women tumour worldwide, about 2 million new cases diagnosed each year (second most common cancer overall). This disease represents about 12% of all new cancer cases and 25% of all cancers in women. Early detection of breast cancer is one of the key factors in determining the prognosis for women with malignant tumours. The standard diagnostic tool for the detection of breast cancer is x-ray mammography. The disadvantage of this method is its low specificity, especially in the case of radiographically dense breast tissue (young or under-forty women), or in the presence of scars and implants within the breast. Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) has demonstrated a great potential in the screening of high-risk women for breast cancer, in staging newly diagnosed patients and in assessing therapy effects. However, due to the large amount of information, DCE-MRI manual examination is error prone and can hardly be inspected without the use of a Computer-Aided Detection and Diagnosis (CAD) system. Breast imaging analysis is made harder by the dynamical characteristics of soft tissues since any patient movements (such as involuntary due to breathing) may affect the voxel-by-voxel dynamical analysis. Breast DCE-MRI computer-aided analysis needs a pre-processing stage to identify breast parenchyma and reduce motion artefacts. Among the major issues in developing CAD for breast DCE-MRI, there is the detection and classification of lesions according to their aggressiveness. Moreover, it would be convenient to determine those subjects who are likely to not respond to the treatment so that a modification may be applied as soon as possible, relieving them from potentially unnecessary or toxic treatments. In this thesis, an automated CAD system is presented. The proposed CAD aims to support radiologist in lesion detection, diagnosis and therapy assessment after a suitable preprocessing stage. Segmentation of breast parenchyma has been addressed relying on fuzzy binary clustering, breast anatomical priors and morphological refinements. The breast mask extraction module combines three 2D Fuzzy C-Means clustering (executed from the three projection, axial, coronal and transversal) and geometrical breast anatomy characterization. In particular, seven well-defined key-points have been considered in order to accurately segment breast parenchyma from air and chest-wall. To diminish the effects of involuntary movement artefacts, it is usual to apply a motion correction of the DCE-MRI volumes before of any data analysis. However, there is no evidence that a single Motion Correction Technique (MCT) can handle different deformations - small or large, rigid or non-rigid - and different patients or tissues. Therefore, it would be useful to develop a quality index (QI) to evaluate the performance of different MCTs. The existent QI might not be adequate to deal with DCE-MRI data because of the intensity variation due to contrast media. Therefore, in developing a novel QI, the underlying idea is that once DCE-MRI data have been realigned using a specific MCT, the dynamic course of the signal intensity should be as close as possible to physiological models, such as the currently accepted ones (e.g. Tofts-Kermode, Extended Tofts-Kermode, Hayton-Brady, Gamma Capillary Transit Time, etc.). The motion correction module ranks all the MCTs, using the QI, selects the best MCT and applies a correction before of further data analysis. The proposed lesion detection module performs the segmentation of lesions in Regions of Interest (ROIs) by means of classification at a pixel level. It is based on a Support Vector Machine (SVM) trained with dynamic features, extracted from a suitably pre-selected area by using a pixel-based approach. The pre-selection mask strongly improves the final result. The lesion classification module evaluates the malignity of each ROI by means of 3D textural features. The Local Binary Patterns descriptor has been used in the Three Orthogonal Planes (LBP-TOP) configuration. A Random Forest has been used to achieve the final classification into a benignant or malignant lesion. The therapy assessment stage aims to predict the patient primary tumour recurrence to support the physician in the evaluation of the therapy effects and benefits. For each patient which has at least a malignant lesion, the recurrence of the disease has been evaluated by means of a multiple classifiers system. A set of dynamic, textural, clinicopathologic and pharmacokinetic features have been used to assess the probability of recurrence for the lesions. Finally, to improve the usability of the proposed work, we developed a framework for tele-medicine that allows advanced medical image remote analysis in a secure and versatile client-server environment, at a low cost. The benefits of using the proposed framework will be presented in a real-case scenario where OsiriX, a wide-spread medical image analysis software, is allowed to perform advanced remote image processing in a simple manner over a secure channel. The proposed CAD system have been tested on real breast DCE-MRI data for the available protocols. The breast mask extraction stage shows a median segmentation accuracy and Dice similarity index of 98% (+/-0,49) and 93% %(+/-1,48) respectively and 100% of neoplastic lesion coverage. The motion correction module is able to rank the MCTs with an accordance of 74% with a 'reference ranking'. Moreover, by only using 40% of the available volume, the computational load is reduced selecting always the best MCT. The automatic detection maximises the area of correctly detected lesions while minimising the number of false alarms with an accuracy of 99% and the lesions are, then, diagnosed according to their stage with an accuracy of 85%. The therapy assessment module provides a forecasting of the tumour recurrence with an accuracy of 78% and an AUC of 79%. Each module has been evaluated by a leave-one-patient-out approach, and results show a confidence level of 95% (p<0.05). Finally, the proposed remote architecture showed a very low transmission overhead which settles on about 2.5% for the widespread 10\100 Mbps. Security has been achieved using client-server certificates and up-to-date standards

Libro de actas. XXXV Congreso Anual de la Sociedad Española de Ingeniería Biomédica

596 p.CASEIB2017 vuelve a ser el foro de referencia a nivel nacional para el intercambio científico de conocimiento, experiencias y promoción de la I D i en Ingeniería Biomédica. Un punto de encuentro de científicos, profesionales de la industria, ingenieros biomédicos y profesionales clínicos interesados en las últimas novedades en investigación, educación y aplicación industrial y clínica de la ingeniería biomédica. En la presente edición, más de 160 trabajos de alto nivel científico serán presentados en áreas relevantes de la ingeniería biomédica, tales como: procesado de señal e imagen, instrumentación biomédica, telemedicina, modelado de sistemas biomédicos, sistemas inteligentes y sensores, robótica, planificación y simulación quirúrgica, biofotónica y biomateriales. Cabe destacar las sesiones dedicadas a la competición por el Premio José María Ferrero Corral, y la sesión de competición de alumnos de Grado en Ingeniería biomédica, que persiguen fomentar la participación de jóvenes estudiantes e investigadores

Immunohistochemical and electrophysiological investigation of E/I balance alterations in animal models of frontotemporal dementia

Behavioural variant frontotemporal dementia (bvFTD) is a neurodegenerative disease characterised by changes in behaviour. Apathy, behavioural disinhibition and stereotyped behaviours are the first symptoms to appear and all have a basis in reward and pleasure deficits. The ventral striatum and ventral regions of the globus pallidus are involved in reward and pleasure. It is therefore reasonable to suggest alterations in these regions may underpin bvFTD. One postulated contributory factor is alteration in E/I balance in striatal regions. GABAergic interneurons play a role in E/I balance, acting as local inhibitory brakes, they are therefore a rational target for research investigating early biological predictors of bvFTD. To investigate this, we will carry out immunohistochemical staining for GABAergic interneurons (parvalbumin and neuronal nitric oxide synthase) in striatal regions of brains taken from CHMP2B mice, a validated animal model of bvFTD. We hypothesise that there will be fewer GABAergic interneurons in the striatum which may lead to ‘reward-seeking’ behaviour in bvFTD. This will also enable us to investigate any preclinical alterations in interneuron expression within this region. Results will be analysed using a mixed ANOVA and if significant, post hoc t-tests will be used. The second part of our study will involve extracellular recordings from CHMP2B mouse brains using a multi-electrode array (MEA). This will enable us to determine if there are alterations in local field potentials (LFP) in preclinical and symptomatic animals. We will also be able to see if neuromodulators such as serotonin and dopamine effect LFPs after bath application. We will develop slice preparations to preserve pathways between the ventral tegmental area and the ventral pallidum, an output structure of the striatum, and the dorsal raphe nucleus and the VP. Using the MEA we will stimulate an endogenous release of dopamine and serotonin using the slice preparations as described above. This will enable us to see if there are any changes in LFPs after endogenous release of neuromodulators. We hypothesise there will be an increase in LFPs due to loss of GABAergic interneurons

Augmentation of Brain Function: Facts, Fiction and Controversy. Volume III: From Clinical Applications to Ethical Issues and Futuristic Ideas

The final volume in this tripartite series on Brain Augmentation is entitled “From Clinical Applications to Ethical Issues and Futuristic Ideas”. Many of the articles within this volume deal with translational efforts taking the results of experiments on laboratory animals and applying them to humans. In many cases, these interventions are intended to help people with disabilities in such a way so as to either restore or extend brain function. Traditionally, therapies in brain augmentation have included electrical and pharmacological techniques. In contrast, some of the techniques discussed in this volume add specificity by targeting select neural populations. This approach opens the door to where and how to promote the best interventions. Along the way, results have empowered the medical profession by expanding their understanding of brain function. Articles in this volume relate novel clinical solutions for a host of neurological and psychiatric conditions such as stroke, Parkinson’s disease, Huntington’s disease, epilepsy, dementia, Alzheimer’s disease, autism spectrum disorders (ASD), traumatic brain injury, and disorders of consciousness. In disease, symptoms and signs denote a departure from normal function. Brain augmentation has now been used to target both the core symptoms that provide specificity in the diagnosis of a disease, as well as other constitutional symptoms that may greatly handicap the individual. The volume provides a report on the use of repetitive transcranial magnetic stimulation (rTMS) in ASD with reported improvements of core deficits (i.e., executive functions). TMS in this regard departs from the present-day trend towards symptomatic treatment that leaves unaltered the root cause of the condition. In diseases, such as schizophrenia, brain augmentation approaches hold promise to avoid lengthy pharmacological interventions that are usually riddled with side effects or those with limiting returns as in the case of Parkinson’s disease. Brain stimulation can also be used to treat auditory verbal hallucination, visuospatial (hemispatial) neglect, and pain in patients suffering from multiple sclerosis. The brain acts as a telecommunication transceiver wherein different bandwidth of frequencies (brainwave oscillations) transmit information. Their baseline levels correlate with certain behavioral states. The proper integration of brain oscillations provides for the phenomenon of binding and central coherence. Brain augmentation may foster the normalization of brain oscillations in nervous system disorders. These techniques hold the promise of being applied remotely (under the supervision of medical personnel), thus overcoming the obstacle of travel in order to obtain healthcare. At present, traditional thinking would argue the possibility of synergism among different modalities of brain augmentation as a way of increasing their overall effectiveness and improving therapeutic selectivity. Thinking outside of the box would also provide for the implementation of brain-to-brain interfaces where techniques, proper to artificial intelligence, could allow us to surpass the limits of natural selection or enable communications between several individual brains sharing memories, or even a global brain capable of self-organization. Not all brains are created equal. Brain stimulation studies suggest large individual variability in response that may affect overall recovery/treatment, or modify desired effects of a given intervention. The subject’s age, gender, hormonal levels may affect an individual’s cortical excitability. In addition, this volume discusses the role of social interactions in the operations of augmenting technologies. Finally, augmenting methods could be applied to modulate consciousness, even though its neural mechanisms are poorly understood. Finally, this volume should be taken as a debate on social, moral and ethical issues on neurotechnologies. Brain enhancement may transform the individual into someone or something else. These techniques bypass the usual routes of accommodation to environmental exigencies that exalted our personal fortitude: learning, exercising, and diet. This will allow humans to preselect desired characteristics and realize consequent rewards without having to overcome adversity through more laborious means. The concern is that humans may be playing God, and the possibility of an expanding gap in social equity where brain enhancements may be selectively available to the wealthier individuals. These issues are discussed by a number of articles in this volume. Also discussed are the relationship between the diminishment and enhancement following the application of brain-augmenting technologies, the problem of “mind control” with BMI technologies, free will the duty to use cognitive enhancers in high-responsibility professions, determining the population of people in need of brain enhancement, informed public policy, cognitive biases, and the hype caused by the development of brain- augmenting approaches

A Systematic Review and Meta-Analysis of the Incidence of Injury in Professional Female Soccer

The epidemiology of injury in male professional football is well documented and has been used as a basis to monitor injury trends and implement injury prevention strategies. There are no systematic reviews that have investigated injury incidence in women’s professional football. Therefore, the extent of injury burden in women’s professional football remains unknown. PURPOSE: The primary aim of this study was to calculate an overall incidence rate of injury in senior female professional soccer. The secondary aims were to provide an incidence rate for training and match play. METHODS: PubMed, Discover, EBSCO, Embase and ScienceDirect electronic databases were searched from inception to September 2018. Two reviewers independently assessed study quality using the Strengthening the Reporting of Observational Studies in Epidemiology statement using a 22-item STROBE checklist. Seven prospective studies (n=1137 professional players) were combined in a pooled analysis of injury incidence using a mixed effects model. Heterogeneity was evaluated using the Cochrane Q statistic and I2. RESULTS: The epidemiological incidence proportion over one season was 0.62 (95% CI 0.59 - 0.64). Mean total incidence of injury was 3.15 (95% CI 1.54 - 4.75) injuries per 1000 hours. The mean incidence of injury during match play was 10.72 (95% CI 9.11 - 12.33) and during training was 2.21 (95% CI 0.96 - 3.45). Data analysis found a significant level of heterogeneity (total Incidence, X2 = 16.57 P < 0.05; I2 = 63.8%) and during subsequent sub group analyses in those studies reviewed (match incidence, X2 = 76.4 (d.f. = 7), P <0.05; I2 = 90.8%, training incidence, X2 = 16.97 (d.f. = 7), P < 0.05; I2 = 58.8%). Appraisal of the study methodologies revealed inconsistency in the use of injury terminology, data collection procedures and calculation of exposure by researchers. Such inconsistencies likely contribute to the large variance in the incidence and prevalence of injury reported. CONCLUSIONS: The estimated risk of sustaining at least one injury over one football season is 62%. Continued reporting of heterogeneous results in population samples limits meaningful comparison of studies. Standardising the criteria used to attribute injury and activity coupled with more accurate methods of calculating exposure will overcome such limitations